Trial intelligence / Profile preview

Daily tadalafil 5 mg for post-void dribbling in men with lower urinary tract symptoms

KCT0002232Phase 4Completed

Sponsor
Chong Kun Dang
Start
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tadalafil in Micturition disorder, None, sponsored by Chong Kun Dang. Started Nov 2017; status: completed.

02

Drugs

tadalafil
03

Conditions

Micturition disorder

Beyond the preview

Go deeper on KCT0002232.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0002232.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call